Rank | Gene Set | Z-score |
---|---|---|
1 | protein neddylation (GO:0045116) | 5.59985301 |
2 | valine metabolic process (GO:0006573) | 5.16611754 |
3 | regulation of sequestering of triglyceride (GO:0010889) | 4.99534935 |
4 | lysine catabolic process (GO:0006554) | 4.92949790 |
5 | lysine metabolic process (GO:0006553) | 4.92949790 |
6 | fatty acid beta-oxidation (GO:0006635) | 4.79634169 |
7 | fatty acid oxidation (GO:0019395) | 4.40416531 |
8 | lipid oxidation (GO:0034440) | 4.37372032 |
9 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36637665 |
10 | tricarboxylic acid metabolic process (GO:0072350) | 4.34920986 |
11 | cysteine metabolic process (GO:0006534) | 4.26491232 |
12 | fatty acid catabolic process (GO:0009062) | 4.18618416 |
13 | fatty acid transmembrane transport (GO:1902001) | 4.15671212 |
14 | microtubule depolymerization (GO:0007019) | 4.15321653 |
15 | thrombin receptor signaling pathway (GO:0070493) | 4.13723866 |
16 | branched-chain amino acid metabolic process (GO:0009081) | 4.10981198 |
17 | negative regulation of appetite (GO:0032099) | 4.08047291 |
18 | negative regulation of response to food (GO:0032096) | 4.08047291 |
19 | 2-oxoglutarate metabolic process (GO:0006103) | 4.05726406 |
20 | short-chain fatty acid metabolic process (GO:0046459) | 3.98500466 |
21 | biotin metabolic process (GO:0006768) | 3.94412310 |
22 | carnitine shuttle (GO:0006853) | 3.91240062 |
23 | meiotic chromosome segregation (GO:0045132) | 3.89465564 |
24 | amino-acid betaine metabolic process (GO:0006577) | 3.88897266 |
25 | branched-chain amino acid catabolic process (GO:0009083) | 3.85257956 |
26 | carnitine metabolic process (GO:0009437) | 3.81566549 |
27 | alpha-linolenic acid metabolic process (GO:0036109) | 3.78404334 |
28 | L-phenylalanine metabolic process (GO:0006558) | 3.77564175 |
29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.77564175 |
30 | L-phenylalanine catabolic process (GO:0006559) | 3.75994416 |
31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.75994416 |
32 | glyoxylate metabolic process (GO:0046487) | 3.75754552 |
33 | low-density lipoprotein particle clearance (GO:0034383) | 3.75485785 |
34 | urate metabolic process (GO:0046415) | 3.74156628 |
35 | acetyl-CoA metabolic process (GO:0006084) | 3.74108549 |
36 | autophagic vacuole fusion (GO:0000046) | 3.71066703 |
37 | monocarboxylic acid catabolic process (GO:0072329) | 3.66126519 |
38 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.60205686 |
39 | positive regulation of fatty acid oxidation (GO:0046321) | 3.59574017 |
40 | regulation of female receptivity (GO:0045924) | 3.58644858 |
41 | amino-acid betaine transport (GO:0015838) | 3.58135402 |
42 | carnitine transport (GO:0015879) | 3.58135402 |
43 | regulation of triglyceride catabolic process (GO:0010896) | 3.57738396 |
44 | regulation of cholesterol storage (GO:0010885) | 3.57395563 |
45 | sulfur amino acid catabolic process (GO:0000098) | 3.57176848 |
46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.52331499 |
47 | regulation of fatty acid oxidation (GO:0046320) | 3.51608480 |
48 | quaternary ammonium group transport (GO:0015697) | 3.47992883 |
49 | drug transmembrane transport (GO:0006855) | 3.46884602 |
50 | aromatic amino acid family catabolic process (GO:0009074) | 3.46166450 |
51 | maturation of 5.8S rRNA (GO:0000460) | 3.38338463 |
52 | tricarboxylic acid cycle (GO:0006099) | 3.37526348 |
53 | carnitine transmembrane transport (GO:1902603) | 3.32008499 |
54 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.30104118 |
55 | female mating behavior (GO:0060180) | 3.27536942 |
56 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.24993455 |
57 | regulation of lipoprotein metabolic process (GO:0050746) | 3.24413080 |
58 | regulation of transmission of nerve impulse (GO:0051969) | 3.21156485 |
59 | tryptophan catabolic process (GO:0006569) | 3.20774653 |
60 | indole-containing compound catabolic process (GO:0042436) | 3.20774653 |
61 | indolalkylamine catabolic process (GO:0046218) | 3.20774653 |
62 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.19956426 |
63 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.19956426 |
64 | positive regulation of lipid catabolic process (GO:0050996) | 3.17906599 |
65 | aspartate family amino acid catabolic process (GO:0009068) | 3.15787950 |
66 | homocysteine metabolic process (GO:0050667) | 3.15284752 |
67 | tryptophan metabolic process (GO:0006568) | 3.13088594 |
68 | positive regulation of lipid storage (GO:0010884) | 3.10836088 |
69 | drug transport (GO:0015893) | 3.09673298 |
70 | pseudouridine synthesis (GO:0001522) | 3.09212669 |
71 | blood coagulation, intrinsic pathway (GO:0007597) | 3.06969850 |
72 | brown fat cell differentiation (GO:0050873) | 3.05886680 |
73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.05833294 |
74 | kynurenine metabolic process (GO:0070189) | 3.05666254 |
75 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.05556636 |
76 | NADH dehydrogenase complex assembly (GO:0010257) | 3.05556636 |
77 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.05556636 |
78 | DNA replication checkpoint (GO:0000076) | 3.05163104 |
79 | aggressive behavior (GO:0002118) | 3.04069902 |
80 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.02902056 |
81 | negative regulation of heart rate (GO:0010459) | 3.02387210 |
82 | triglyceride catabolic process (GO:0019433) | 3.02122452 |
83 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.00609008 |
84 | organic acid catabolic process (GO:0016054) | 3.00496921 |
85 | carboxylic acid catabolic process (GO:0046395) | 3.00496921 |
86 | succinate metabolic process (GO:0006105) | 2.99102611 |
87 | NADH metabolic process (GO:0006734) | 2.99096741 |
88 | serine family amino acid catabolic process (GO:0009071) | 2.98104544 |
89 | ethanol oxidation (GO:0006069) | 2.97599672 |
90 | plasma lipoprotein particle clearance (GO:0034381) | 2.96633228 |
91 | lipid storage (GO:0019915) | 2.96083897 |
92 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.93078610 |
93 | polyamine biosynthetic process (GO:0006596) | 2.90279930 |
94 | cellular modified amino acid catabolic process (GO:0042219) | 2.90278417 |
95 | complement activation, alternative pathway (GO:0006957) | 2.90015894 |
96 | cellular ketone body metabolic process (GO:0046950) | 2.89842606 |
97 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.89648288 |
98 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.88903156 |
99 | response to phenylpropanoid (GO:0080184) | 2.88409010 |
100 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.87691782 |
101 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.87594730 |
102 | intracellular lipid transport (GO:0032365) | 2.86024905 |
103 | platelet dense granule organization (GO:0060155) | 2.85356615 |
104 | bile acid biosynthetic process (GO:0006699) | 2.84286593 |
105 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.83743191 |
106 | regulation of cholesterol metabolic process (GO:0090181) | 2.83497990 |
107 | phospholipid homeostasis (GO:0055091) | 2.81853675 |
108 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.80838280 |
109 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.80838280 |
110 | organelle membrane fusion (GO:0090174) | 2.80596935 |
111 | oxaloacetate metabolic process (GO:0006107) | 2.80230125 |
112 | acylglycerol catabolic process (GO:0046464) | 2.79256553 |
113 | neutral lipid catabolic process (GO:0046461) | 2.79256553 |
114 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.79230997 |
115 | response to mercury ion (GO:0046689) | 2.78935119 |
116 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.78538648 |
117 | urea cycle (GO:0000050) | 2.78504188 |
118 | urea metabolic process (GO:0019627) | 2.78504188 |
119 | cellular amino acid catabolic process (GO:0009063) | 2.77688554 |
120 | negative regulation of lipid storage (GO:0010888) | 2.76928558 |
121 | response to misfolded protein (GO:0051788) | 2.76376699 |
122 | peptidyl-histidine modification (GO:0018202) | 2.76171759 |
123 | maternal behavior (GO:0042711) | 2.75253832 |
124 | regulation of cholesterol homeostasis (GO:2000188) | 2.75074738 |
125 | alpha-amino acid catabolic process (GO:1901606) | 2.73940648 |
126 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.72471577 |
127 | drug catabolic process (GO:0042737) | 2.71638296 |
128 | acylglycerol homeostasis (GO:0055090) | 2.70845536 |
129 | triglyceride homeostasis (GO:0070328) | 2.70845536 |
130 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.69227902 |
131 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.68512019 |
132 | DNA strand elongation (GO:0022616) | 2.67694006 |
133 | protein K6-linked ubiquitination (GO:0085020) | 2.67359377 |
134 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.65789662 |
135 | metallo-sulfur cluster assembly (GO:0031163) | 2.65580247 |
136 | iron-sulfur cluster assembly (GO:0016226) | 2.65580247 |
137 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.63962990 |
138 | protein complex biogenesis (GO:0070271) | 2.63055164 |
139 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.62032859 |
140 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.61994914 |
141 | nitrogen cycle metabolic process (GO:0071941) | 2.61623094 |
142 | thioester metabolic process (GO:0035383) | 2.60852740 |
143 | acyl-CoA metabolic process (GO:0006637) | 2.60852740 |
144 | polyamine metabolic process (GO:0006595) | 2.60838303 |
145 | negative regulation of protein localization to cell surface (GO:2000009) | 2.60755761 |
146 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.60709816 |
147 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.58742032 |
148 | protein carboxylation (GO:0018214) | 2.58606551 |
149 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.58606551 |
150 | endosome to melanosome transport (GO:0035646) | 2.57662234 |
151 | endosome to pigment granule transport (GO:0043485) | 2.57662234 |
152 | dopamine transport (GO:0015872) | 2.55901210 |
153 | fructose metabolic process (GO:0006000) | 2.55638464 |
154 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.55602225 |
155 | regulation of response to food (GO:0032095) | 2.55585237 |
156 | chromatin remodeling at centromere (GO:0031055) | 2.53359121 |
157 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.52362281 |
158 | CENP-A containing nucleosome assembly (GO:0034080) | 2.49376572 |
159 | regulation of appetite (GO:0032098) | 2.48487661 |
160 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.48346962 |
161 | reciprocal DNA recombination (GO:0035825) | 2.47922222 |
162 | reciprocal meiotic recombination (GO:0007131) | 2.47922222 |
163 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.46880563 |
164 | behavioral response to nicotine (GO:0035095) | 2.46348585 |
165 | regulation of endothelial cell differentiation (GO:0045601) | 2.44347161 |
166 | amine biosynthetic process (GO:0009309) | 2.42678036 |
167 | methionine biosynthetic process (GO:0009086) | 2.41938489 |
168 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.41925200 |
169 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.40257057 |
170 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.40257057 |
171 | parental behavior (GO:0060746) | 2.39031329 |
172 | regulation of cellular respiration (GO:0043457) | 2.38421685 |
173 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.38124093 |
174 | fatty acid elongation (GO:0030497) | 2.34672196 |
175 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.32578229 |
176 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.31049632 |
177 | double-strand break repair via homologous recombination (GO:0000724) | 2.30285897 |
178 | DNA replication initiation (GO:0006270) | 2.30266243 |
179 | recombinational repair (GO:0000725) | 2.29371225 |
180 | mitotic nuclear envelope reassembly (GO:0007084) | 2.29095984 |
181 | nuclear envelope reassembly (GO:0031468) | 2.29095984 |
182 | response to pheromone (GO:0019236) | 2.28716845 |
183 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.28219453 |
184 | positive regulation of vascular permeability (GO:0043117) | 2.26823936 |
185 | DNA-dependent DNA replication (GO:0006261) | 2.26716403 |
186 | ubiquinone biosynthetic process (GO:0006744) | 2.26260471 |
187 | mitochondrial RNA metabolic process (GO:0000959) | 2.26064721 |
188 | ribosome biogenesis (GO:0042254) | 2.24227683 |
189 | L-methionine salvage (GO:0071267) | 2.24166067 |
190 | L-methionine biosynthetic process (GO:0071265) | 2.24166067 |
191 | amino acid salvage (GO:0043102) | 2.24166067 |
192 | angiogenesis involved in wound healing (GO:0060055) | 2.23989844 |
193 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.23620346 |
194 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.23620346 |
195 | microtubule polymerization or depolymerization (GO:0031109) | 2.23171629 |
196 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.22902136 |
197 | glycerophospholipid catabolic process (GO:0046475) | 2.22189212 |
198 | methionine metabolic process (GO:0006555) | 2.22147205 |
199 | tRNA processing (GO:0008033) | 2.21119952 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.14484418 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.46747059 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.09821592 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.85792453 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.40054046 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.00762197 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.90064950 |
8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.74366488 |
9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.08519639 |
10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.90624510 |
11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.86498692 |
12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.85542713 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71801240 |
14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.69133366 |
15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.64008794 |
16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.40335997 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39416401 |
18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32467770 |
19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.31928515 |
20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.31171516 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.29946688 |
22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.27920685 |
23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.27556219 |
24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.25428975 |
25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.23351005 |
26 | MYC_18940864_ChIP-ChIP_HL60_Human | 2.21972671 |
27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.20859596 |
28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.15888188 |
29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13672058 |
30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12015142 |
31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.10686090 |
32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08639990 |
33 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.08141932 |
34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05817223 |
35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.99254168 |
36 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.97725916 |
37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.96777280 |
38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.93112564 |
39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.92839897 |
40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92362208 |
41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.92069143 |
42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88518272 |
43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.85575940 |
44 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.85118173 |
45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84516103 |
46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83657052 |
47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83567202 |
48 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81383424 |
49 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.80599996 |
50 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76963194 |
51 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.76533943 |
52 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.76431284 |
53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76290320 |
54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.70221662 |
55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64303041 |
56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.63819981 |
57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.62976608 |
58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.61469012 |
59 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.60763826 |
60 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.60285715 |
61 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.57838356 |
62 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.57602848 |
63 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.57239411 |
64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53985179 |
65 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51184891 |
66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.50787702 |
67 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.47207965 |
68 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.46896576 |
69 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46011236 |
70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.44312951 |
71 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.44312609 |
72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44193466 |
73 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.42189078 |
74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40098723 |
75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39826517 |
76 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37378557 |
77 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.36458477 |
78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35825608 |
79 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.35720257 |
80 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.35187880 |
81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34025047 |
82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30733738 |
83 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.30554996 |
84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30424640 |
85 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30123025 |
86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28871806 |
87 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26900660 |
88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26716732 |
89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.26527062 |
90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26344408 |
91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26082099 |
92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26006540 |
93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25282062 |
94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24560777 |
95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22409867 |
96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22231550 |
97 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.22104336 |
98 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.21482006 |
99 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20995050 |
100 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20232131 |
101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19410571 |
102 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.19105476 |
103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17146465 |
104 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16523420 |
105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.16362310 |
106 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16258100 |
107 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16258100 |
108 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.15458779 |
109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13842005 |
110 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13311213 |
111 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10520518 |
112 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10520518 |
113 | MAF_26560356_Chip-Seq_TH1_Human | 1.10396779 |
114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.09523564 |
115 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09220934 |
116 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.08578379 |
117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08396098 |
118 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.07885272 |
119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07268350 |
120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06557041 |
121 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06296953 |
122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05189925 |
123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04302056 |
124 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04286496 |
125 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04016781 |
126 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03837973 |
127 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03726656 |
128 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.03654036 |
129 | AR_20517297_ChIP-Seq_VCAP_Human | 1.03154912 |
130 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02350892 |
131 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00913134 |
132 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00744376 |
133 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00668167 |
134 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99100735 |
135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99005330 |
136 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98842679 |
137 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.98230947 |
138 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97691694 |
139 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96766685 |
140 | MYB_26560356_Chip-Seq_TH2_Human | 0.96566135 |
141 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96428851 |
142 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96100722 |
143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95742842 |
144 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95728576 |
145 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95431595 |
146 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95086117 |
147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94760412 |
148 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.94576694 |
149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94344486 |
150 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93644859 |
151 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.93468960 |
152 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92529608 |
153 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91937868 |
154 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91877852 |
155 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.91442585 |
156 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.91224108 |
157 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90577583 |
158 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90300045 |
159 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89598270 |
160 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89416669 |
161 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.89348837 |
162 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89243013 |
163 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89024379 |
164 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.88822185 |
165 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88749517 |
166 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88378511 |
167 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88257159 |
168 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88186777 |
169 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88128191 |
170 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.87076662 |
171 | MYB_26560356_Chip-Seq_TH1_Human | 0.86785130 |
172 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86169817 |
173 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86006909 |
174 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85702467 |
175 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.85410645 |
176 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85277223 |
177 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.84401743 |
178 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84039314 |
179 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83713203 |
180 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.83370440 |
181 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83128495 |
182 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82428763 |
183 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.82175514 |
184 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.81782138 |
185 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81532831 |
186 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80489773 |
187 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79710909 |
188 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.78603778 |
189 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.78525770 |
190 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77882109 |
191 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77564062 |
192 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77185842 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.51386628 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.04849895 |
3 | MP0004147_increased_porphyrin_level | 3.56340109 |
4 | MP0005365_abnormal_bile_salt | 3.25035049 |
5 | MP0003718_maternal_effect | 3.19166944 |
6 | MP0002736_abnormal_nociception_after | 2.83079914 |
7 | MP0005670_abnormal_white_adipose | 2.81868061 |
8 | MP0005085_abnormal_gallbladder_physiolo | 2.81867704 |
9 | MP0002102_abnormal_ear_morphology | 2.67853150 |
10 | MP0008004_abnormal_stomach_pH | 2.64688433 |
11 | MP0004130_abnormal_muscle_cell | 2.60528763 |
12 | MP0009840_abnormal_foam_cell | 2.47173163 |
13 | MP0005332_abnormal_amino_acid | 2.45051103 |
14 | MP0005666_abnormal_adipose_tissue | 2.44855082 |
15 | MP0003646_muscle_fatigue | 2.42293045 |
16 | MP0010094_abnormal_chromosome_stability | 2.40258877 |
17 | MP0002877_abnormal_melanocyte_morpholog | 2.37114612 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.33867640 |
19 | MP0008872_abnormal_physiological_respon | 2.29621397 |
20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.27500477 |
21 | MP0010329_abnormal_lipoprotein_level | 2.26468789 |
22 | MP0003195_calcinosis | 2.26097834 |
23 | MP0005645_abnormal_hypothalamus_physiol | 2.17458302 |
24 | MP0003252_abnormal_bile_duct | 2.16784551 |
25 | MP0002138_abnormal_hepatobiliary_system | 2.06860870 |
26 | MP0001968_abnormal_touch/_nociception | 2.04649960 |
27 | MP0004185_abnormal_adipocyte_glucose | 2.00651768 |
28 | MP0008877_abnormal_DNA_methylation | 1.98300940 |
29 | MP0003693_abnormal_embryo_hatching | 1.98195778 |
30 | MP0009643_abnormal_urine_homeostasis | 1.94653154 |
31 | MP0003136_yellow_coat_color | 1.89403045 |
32 | MP0003724_increased_susceptibility_to | 1.88549192 |
33 | MP0002971_abnormal_brown_adipose | 1.88322600 |
34 | MP0004019_abnormal_vitamin_homeostasis | 1.81884914 |
35 | MP0008058_abnormal_DNA_repair | 1.81455243 |
36 | MP0005058_abnormal_lysosome_morphology | 1.81236556 |
37 | MP0003186_abnormal_redox_activity | 1.80445274 |
38 | MP0002118_abnormal_lipid_homeostasis | 1.79848137 |
39 | MP0008932_abnormal_embryonic_tissue | 1.76174694 |
40 | MP0000609_abnormal_liver_physiology | 1.75183036 |
41 | MP0003436_decreased_susceptibility_to | 1.73437770 |
42 | MP0004043_abnormal_pH_regulation | 1.72363298 |
43 | MP0001835_abnormal_antigen_presentation | 1.68698652 |
44 | MP0004957_abnormal_blastocyst_morpholog | 1.66885238 |
45 | MP0004142_abnormal_muscle_tone | 1.64688106 |
46 | MP0002837_dystrophic_cardiac_calcinosis | 1.62767305 |
47 | MP0005646_abnormal_pituitary_gland | 1.62284782 |
48 | MP0005319_abnormal_enzyme/_coenzyme | 1.59082152 |
49 | MP0003111_abnormal_nucleus_morphology | 1.59047487 |
50 | MP0004084_abnormal_cardiac_muscle | 1.58666161 |
51 | MP0002733_abnormal_thermal_nociception | 1.57918021 |
52 | MP0000015_abnormal_ear_pigmentation | 1.56077006 |
53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55890504 |
54 | MP0005174_abnormal_tail_pigmentation | 1.53708635 |
55 | MP0009697_abnormal_copulation | 1.53668374 |
56 | MP0005375_adipose_tissue_phenotype | 1.53003415 |
57 | MP0001666_abnormal_nutrient_absorption | 1.52180013 |
58 | MP0005501_abnormal_skin_physiology | 1.51963446 |
59 | MP0002638_abnormal_pupillary_reflex | 1.51802919 |
60 | MP0008057_abnormal_DNA_replication | 1.50854540 |
61 | MP0003806_abnormal_nucleotide_metabolis | 1.49657111 |
62 | MP0003638_abnormal_response/metabolism_ | 1.46035211 |
63 | MP0001853_heart_inflammation | 1.45794779 |
64 | MP0000647_abnormal_sebaceous_gland | 1.44723315 |
65 | MP0003300_gastrointestinal_ulcer | 1.44214055 |
66 | MP0009785_altered_susceptibility_to | 1.43743147 |
67 | MP0009046_muscle_twitch | 1.43474396 |
68 | MP0006036_abnormal_mitochondrial_physio | 1.42838265 |
69 | MP0005451_abnormal_body_composition | 1.39880613 |
70 | MP0000465_gastrointestinal_hemorrhage | 1.39500440 |
71 | MP0002254_reproductive_system_inflammat | 1.37525664 |
72 | MP0009764_decreased_sensitivity_to | 1.35392817 |
73 | MP0004215_abnormal_myocardial_fiber | 1.34806735 |
74 | MP0009379_abnormal_foot_pigmentation | 1.33944157 |
75 | MP0005535_abnormal_body_temperature | 1.32985941 |
76 | MP0008469_abnormal_protein_level | 1.31533680 |
77 | MP0002938_white_spotting | 1.31146174 |
78 | MP0005171_absent_coat_pigmentation | 1.30189909 |
79 | MP0000343_altered_response_to | 1.29051286 |
80 | MP0009115_abnormal_fat_cell | 1.27567586 |
81 | MP0000685_abnormal_immune_system | 1.24732772 |
82 | MP0002136_abnormal_kidney_physiology | 1.24425346 |
83 | MP0005334_abnormal_fat_pad | 1.23342798 |
84 | MP0001756_abnormal_urination | 1.21397999 |
85 | MP0002419_abnormal_innate_immunity | 1.19437410 |
86 | MP0002095_abnormal_skin_pigmentation | 1.18662859 |
87 | MP0006035_abnormal_mitochondrial_morpho | 1.17327122 |
88 | MP0005025_abnormal_response_to | 1.16621661 |
89 | MP0005083_abnormal_biliary_tract | 1.14924376 |
90 | MP0006276_abnormal_autonomic_nervous | 1.13358125 |
91 | MP0005410_abnormal_fertilization | 1.12772657 |
92 | MP0005636_abnormal_mineral_homeostasis | 1.11908076 |
93 | MP0005000_abnormal_immune_tolerance | 1.11688772 |
94 | MP0001485_abnormal_pinna_reflex | 1.11639286 |
95 | MP0003705_abnormal_hypodermis_morpholog | 1.09327883 |
96 | MP0005387_immune_system_phenotype | 1.07291340 |
97 | MP0001790_abnormal_immune_system | 1.07291340 |
98 | MP0001765_abnormal_ion_homeostasis | 1.06246264 |
99 | MP0002148_abnormal_hypersensitivity_rea | 1.05997680 |
100 | MP0002078_abnormal_glucose_homeostasis | 1.05245909 |
101 | MP0002166_altered_tumor_susceptibility | 1.04815358 |
102 | MP0002653_abnormal_ependyma_morphology | 1.04511980 |
103 | MP0001970_abnormal_pain_threshold | 1.03431237 |
104 | MP0005167_abnormal_blood-brain_barrier | 1.03195611 |
105 | MP0001845_abnormal_inflammatory_respons | 1.03032366 |
106 | MP0005551_abnormal_eye_electrophysiolog | 1.02242215 |
107 | MP0005187_abnormal_penis_morphology | 0.99517148 |
108 | MP0000358_abnormal_cell_content/ | 0.99414643 |
109 | MP0002160_abnormal_reproductive_system | 0.97470100 |
110 | MP0009763_increased_sensitivity_to | 0.97418987 |
111 | MP0003656_abnormal_erythrocyte_physiolo | 0.97312040 |
112 | MP0000383_abnormal_hair_follicle | 0.97030403 |
113 | MP0000631_abnormal_neuroendocrine_gland | 0.97026679 |
114 | MP0004885_abnormal_endolymph | 0.97008404 |
115 | MP0005330_cardiomyopathy | 0.96726341 |
116 | MP0001800_abnormal_humoral_immune | 0.94596903 |
117 | MP0004947_skin_inflammation | 0.94144660 |
118 | MP0001764_abnormal_homeostasis | 0.93514966 |
119 | MP0006082_CNS_inflammation | 0.93251871 |
120 | MP0003303_peritoneal_inflammation | 0.92623439 |
121 | MP0001533_abnormal_skeleton_physiology | 0.92041863 |
122 | MP0003077_abnormal_cell_cycle | 0.92005263 |
123 | MP0002970_abnormal_white_adipose | 0.91904364 |
124 | MP0004085_abnormal_heartbeat | 0.91529873 |
125 | MP0002234_abnormal_pharynx_morphology | 0.91290291 |
126 | MP0005084_abnormal_gallbladder_morpholo | 0.91251506 |
127 | MP0000598_abnormal_liver_morphology | 0.91092954 |
128 | MP0002452_abnormal_antigen_presenting | 0.90253591 |
129 | MP0008961_abnormal_basal_metabolism | 0.90021659 |
130 | MP0005464_abnormal_platelet_physiology | 0.89588907 |
131 | MP0003950_abnormal_plasma_membrane | 0.88739057 |
132 | MP0010155_abnormal_intestine_physiology | 0.87634202 |
133 | MP0000372_irregular_coat_pigmentation | 0.87005342 |
134 | MP0003075_altered_response_to | 0.86666239 |
135 | MP0002723_abnormal_immune_serum | 0.86328151 |
136 | MP0004510_myositis | 0.86018174 |
137 | MP0009745_abnormal_behavioral_response | 0.83832992 |
138 | MP0003879_abnormal_hair_cell | 0.83788484 |
139 | MP0008775_abnormal_heart_ventricle | 0.83548225 |
140 | MP0005671_abnormal_response_to | 0.83362935 |
141 | MP0002876_abnormal_thyroid_physiology | 0.82504964 |
142 | MP0009642_abnormal_blood_homeostasis | 0.82456822 |
143 | MP0001905_abnormal_dopamine_level | 0.82136145 |
144 | MP0003890_abnormal_embryonic-extraembry | 0.81982926 |
145 | MP0004782_abnormal_surfactant_physiolog | 0.81936372 |
146 | MP0003690_abnormal_glial_cell | 0.81934715 |
147 | MP0001188_hyperpigmentation | 0.81792964 |
148 | MP0003828_pulmonary_edema | 0.81335594 |
149 | MP0002272_abnormal_nervous_system | 0.78660995 |
150 | MP0006292_abnormal_olfactory_placode | 0.78123358 |
151 | MP0002006_tumorigenesis | 0.77252051 |
152 | MP0010771_integument_phenotype | 0.76230062 |
153 | MP0005165_increased_susceptibility_to | 0.75678865 |
154 | MP0004924_abnormal_behavior | 0.75304477 |
155 | MP0005386_behavior/neurological_phenoty | 0.75304477 |
156 | MP0009780_abnormal_chondrocyte_physiolo | 0.74174249 |
157 | MP0000230_abnormal_systemic_arterial | 0.74156181 |
158 | MP0005385_cardiovascular_system_phenoty | 0.74145005 |
159 | MP0001544_abnormal_cardiovascular_syste | 0.74145005 |
160 | MP0002210_abnormal_sex_determination | 0.74143952 |
161 | MP0005448_abnormal_energy_balance | 0.73340841 |
162 | MP0001697_abnormal_embryo_size | 0.72578417 |
163 | MP0001819_abnormal_immune_cell | 0.72535538 |
164 | MP0008770_decreased_survivor_rate | 0.71710080 |
165 | MP0002420_abnormal_adaptive_immunity | 0.71569642 |
166 | MP0002796_impaired_skin_barrier | 0.70696232 |
167 | MP0000013_abnormal_adipose_tissue | 0.70058187 |
168 | MP0001293_anophthalmia | 0.69395870 |
169 | MP0004087_abnormal_muscle_fiber | 0.69192124 |
170 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69140086 |
171 | MP0008007_abnormal_cellular_replicative | 0.69123385 |
172 | MP0002067_abnormal_sensory_capabilities | 0.68989599 |
173 | MP0003698_abnormal_male_reproductive | 0.68796682 |
174 | MP0001664_abnormal_digestion | 0.68570867 |
175 | MP0001730_embryonic_growth_arrest | 0.67911806 |
176 | MP0001929_abnormal_gametogenesis | 0.65216180 |
177 | MP0002572_abnormal_emotion/affect_behav | 0.64986162 |
178 | MP0001881_abnormal_mammary_gland | 0.64753640 |
179 | MP0002084_abnormal_developmental_patter | 0.64622715 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased mean platelet volume (HP:0011877) | 5.98422313 |
2 | Prolonged bleeding time (HP:0003010) | 5.49191781 |
3 | Menorrhagia (HP:0000132) | 5.23495311 |
4 | Abnormal platelet volume (HP:0011876) | 5.12536322 |
5 | Hypoglycemic coma (HP:0001325) | 4.94210822 |
6 | Petechiae (HP:0000967) | 4.89910119 |
7 | Hyperglycinuria (HP:0003108) | 4.83223485 |
8 | Abnormality of alanine metabolism (HP:0010916) | 4.34163948 |
9 | Hyperalaninemia (HP:0003348) | 4.34163948 |
10 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.34163948 |
11 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.28951977 |
12 | Generalized aminoaciduria (HP:0002909) | 4.18963398 |
13 | Ketoacidosis (HP:0001993) | 4.10975121 |
14 | Abnormality of glycine metabolism (HP:0010895) | 4.07317553 |
15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.07317553 |
16 | Ketosis (HP:0001946) | 4.04459595 |
17 | Purpura (HP:0000979) | 3.73993499 |
18 | Hyperammonemia (HP:0001987) | 3.71296656 |
19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.70810739 |
20 | Xanthomatosis (HP:0000991) | 3.68879132 |
21 | Dicarboxylic aciduria (HP:0003215) | 3.63936845 |
22 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.63936845 |
23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.33329533 |
24 | Abnormality of purine metabolism (HP:0004352) | 3.29276188 |
25 | Proximal tubulopathy (HP:0000114) | 3.27748977 |
26 | Acanthocytosis (HP:0001927) | 3.26011881 |
27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23618634 |
28 | Hydroxyprolinuria (HP:0003080) | 3.23173541 |
29 | Abnormality of proline metabolism (HP:0010907) | 3.23173541 |
30 | Myoglobinuria (HP:0002913) | 3.21072848 |
31 | Gout (HP:0001997) | 3.20679057 |
32 | Birth length less than 3rd percentile (HP:0003561) | 3.18651271 |
33 | Hyperglycinemia (HP:0002154) | 3.11941417 |
34 | Acute encephalopathy (HP:0006846) | 3.01211853 |
35 | Nausea (HP:0002018) | 2.99837508 |
36 | Hyperthyroidism (HP:0000836) | 2.96962308 |
37 | Complement deficiency (HP:0004431) | 2.92119179 |
38 | Acute necrotizing encephalopathy (HP:0006965) | 2.91967614 |
39 | Hyperlipoproteinemia (HP:0010980) | 2.86648993 |
40 | Vacuolated lymphocytes (HP:0001922) | 2.84000515 |
41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.77726103 |
42 | Intrahepatic cholestasis (HP:0001406) | 2.74143804 |
43 | Hyperuricemia (HP:0002149) | 2.72818646 |
44 | Increased purine levels (HP:0004368) | 2.72818646 |
45 | Poikilocytosis (HP:0004447) | 2.72501905 |
46 | Abnormal platelet function (HP:0011869) | 2.72017692 |
47 | Impaired platelet aggregation (HP:0003540) | 2.72017692 |
48 | Hypoalphalipoproteinemia (HP:0003233) | 2.70402670 |
49 | Metabolic acidosis (HP:0001942) | 2.68099726 |
50 | Myocardial infarction (HP:0001658) | 2.65920869 |
51 | Systemic lupus erythematosus (HP:0002725) | 2.61705455 |
52 | Rhabdomyolysis (HP:0003201) | 2.61216000 |
53 | Autoimmune thrombocytopenia (HP:0001973) | 2.60194556 |
54 | Abnormal pupillary function (HP:0007686) | 2.59591511 |
55 | Epidermoid cyst (HP:0200040) | 2.58640435 |
56 | Abnormality of nucleobase metabolism (HP:0010932) | 2.57445731 |
57 | Breast hypoplasia (HP:0003187) | 2.52855621 |
58 | Epistaxis (HP:0000421) | 2.52638020 |
59 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52553450 |
60 | Hypoglycemic seizures (HP:0002173) | 2.51038040 |
61 | Hepatic necrosis (HP:0002605) | 2.48869376 |
62 | Deep venous thrombosis (HP:0002625) | 2.48799814 |
63 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.48395405 |
64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44722985 |
65 | Abnormal number of erythroid precursors (HP:0012131) | 2.44424312 |
66 | Axonal loss (HP:0003447) | 2.44340752 |
67 | Hypomagnesemia (HP:0002917) | 2.42015072 |
68 | Abnormality of serum amino acid levels (HP:0003112) | 2.38308761 |
69 | Increased muscle lipid content (HP:0009058) | 2.37915200 |
70 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.36306272 |
71 | Pancreatitis (HP:0001733) | 2.35088416 |
72 | Lethargy (HP:0001254) | 2.33697001 |
73 | Abnormality of urine glucose concentration (HP:0011016) | 2.32369951 |
74 | Glycosuria (HP:0003076) | 2.32369951 |
75 | Vomiting (HP:0002013) | 2.31574990 |
76 | Large for gestational age (HP:0001520) | 2.30776839 |
77 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30650553 |
78 | Abnormality of magnesium homeostasis (HP:0004921) | 2.30407484 |
79 | Progressive macrocephaly (HP:0004481) | 2.28933221 |
80 | Hypertriglyceridemia (HP:0002155) | 2.28575476 |
81 | Mitochondrial inheritance (HP:0001427) | 2.27634835 |
82 | Congenital stationary night blindness (HP:0007642) | 2.27345913 |
83 | Hypolipoproteinemia (HP:0010981) | 2.25699625 |
84 | Hypokalemic alkalosis (HP:0001949) | 2.25482715 |
85 | Abnormality of the common coagulation pathway (HP:0010990) | 2.23523139 |
86 | Late onset (HP:0003584) | 2.23447536 |
87 | Dysautonomia (HP:0002459) | 2.23019092 |
88 | Joint hemorrhage (HP:0005261) | 2.21325754 |
89 | Abnormality of complement system (HP:0005339) | 2.20440462 |
90 | Eczematoid dermatitis (HP:0000976) | 2.20154464 |
91 | Chromsome breakage (HP:0040012) | 2.20149870 |
92 | Hyperactive renin-angiotensin system (HP:0000841) | 2.19194074 |
93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19071810 |
94 | Upper limb muscle weakness (HP:0003484) | 2.18146640 |
95 | Abnormality of the renal cortex (HP:0011035) | 2.17923885 |
96 | Abnormality of chloride homeostasis (HP:0011422) | 2.17860495 |
97 | Increased CSF lactate (HP:0002490) | 2.12421126 |
98 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11258221 |
99 | Molar tooth sign on MRI (HP:0002419) | 2.08960158 |
100 | Abnormality of midbrain morphology (HP:0002418) | 2.08960158 |
101 | Abnormality of the diencephalon (HP:0010662) | 2.08912243 |
102 | Renal cortical cysts (HP:0000803) | 2.08570803 |
103 | 3-Methylglutaconic aciduria (HP:0003535) | 2.08287492 |
104 | Abnormal auditory evoked potentials (HP:0006958) | 2.07005429 |
105 | Polycythemia (HP:0001901) | 2.03763837 |
106 | Pancreatic cysts (HP:0001737) | 2.03629787 |
107 | Methylmalonic aciduria (HP:0012120) | 2.03205518 |
108 | Cerebral edema (HP:0002181) | 2.03101981 |
109 | Increased serum lactate (HP:0002151) | 2.02032197 |
110 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01685424 |
111 | Mucopolysacchariduria (HP:0008155) | 2.01685424 |
112 | Delayed CNS myelination (HP:0002188) | 2.01432427 |
113 | Metabolic alkalosis (HP:0200114) | 2.00759672 |
114 | Prolonged partial thromboplastin time (HP:0003645) | 1.99899961 |
115 | Tetraparesis (HP:0002273) | 1.99759737 |
116 | Type II lissencephaly (HP:0007260) | 1.98793577 |
117 | Sensorimotor neuropathy (HP:0007141) | 1.98681662 |
118 | Dysostosis multiplex (HP:0000943) | 1.97428242 |
119 | Recurrent bacterial skin infections (HP:0005406) | 1.95399863 |
120 | Skin nodule (HP:0200036) | 1.95390199 |
121 | Esophageal varix (HP:0002040) | 1.94613960 |
122 | Symptomatic seizures (HP:0011145) | 1.94261215 |
123 | Absent thumb (HP:0009777) | 1.94185267 |
124 | Lissencephaly (HP:0001339) | 1.93596618 |
125 | Asymmetric septal hypertrophy (HP:0001670) | 1.93450292 |
126 | Abnormality of macrophages (HP:0004311) | 1.92773757 |
127 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.92747781 |
128 | Hyperglycemia (HP:0003074) | 1.91977295 |
129 | Thyroid-stimulating hormone excess (HP:0002925) | 1.90687385 |
130 | Chorioretinal atrophy (HP:0000533) | 1.90361775 |
131 | Truncus arteriosus (HP:0001660) | 1.90128657 |
132 | Inability to walk (HP:0002540) | 1.89184006 |
133 | Hypercholesterolemia (HP:0003124) | 1.88704289 |
134 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88527709 |
135 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88527709 |
136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88527709 |
137 | Hyperventilation (HP:0002883) | 1.87365053 |
138 | Tubular atrophy (HP:0000092) | 1.86061171 |
139 | Alkalosis (HP:0001948) | 1.86021675 |
140 | Hemorrhage of the eye (HP:0011885) | 1.85410744 |
141 | Hypobetalipoproteinemia (HP:0003563) | 1.85063487 |
142 | Pachygyria (HP:0001302) | 1.84992081 |
143 | Conjunctival hamartoma (HP:0100780) | 1.83813013 |
144 | Microretrognathia (HP:0000308) | 1.83515664 |
145 | Abnormal cartilage morphology (HP:0002763) | 1.82902550 |
146 | Progressive microcephaly (HP:0000253) | 1.82046650 |
147 | Abnormality of the pons (HP:0007361) | 1.81842896 |
148 | Bone cyst (HP:0012062) | 1.81166791 |
149 | Recurrent abscess formation (HP:0002722) | 1.80848814 |
150 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.80802757 |
151 | Abnormal urine output (HP:0012590) | 1.80775644 |
152 | Lactic acidosis (HP:0003128) | 1.80725810 |
153 | Paralysis (HP:0003470) | 1.80437566 |
154 | Fat malabsorption (HP:0002630) | 1.80291452 |
155 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.80242185 |
156 | Abnormal drinking behavior (HP:0030082) | 1.79587652 |
157 | Polydipsia (HP:0001959) | 1.79587652 |
158 | Insulin resistance (HP:0000855) | 1.79341692 |
159 | Oligomenorrhea (HP:0000876) | 1.79161493 |
160 | Abnormality of renal excretion (HP:0011036) | 1.78463540 |
161 | Patellar aplasia (HP:0006443) | 1.76332443 |
162 | Abnormality of the carotid arteries (HP:0005344) | 1.75531271 |
163 | Hepatocellular necrosis (HP:0001404) | 1.75513506 |
164 | Cerebellar dysplasia (HP:0007033) | 1.75392841 |
165 | Tinnitus (HP:0000360) | 1.72381955 |
166 | Attenuation of retinal blood vessels (HP:0007843) | 1.71282982 |
167 | Pancreatic fibrosis (HP:0100732) | 1.68828948 |
168 | Severe muscular hypotonia (HP:0006829) | 1.68597078 |
169 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.68537636 |
170 | Elfin facies (HP:0004428) | 1.67844135 |
171 | Hypoplasia of the pons (HP:0012110) | 1.67292356 |
172 | Dyschromatopsia (HP:0007641) | 1.66509746 |
173 | Nephronophthisis (HP:0000090) | 1.65351768 |
174 | Tongue fasciculations (HP:0001308) | 1.65021883 |
175 | Reticulocytopenia (HP:0001896) | 1.64882929 |
176 | Duplicated collecting system (HP:0000081) | 1.63784433 |
177 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.62119474 |
178 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.62119474 |
179 | Renal Fanconi syndrome (HP:0001994) | 1.62003537 |
180 | Gingival bleeding (HP:0000225) | 1.61886604 |
181 | Increased intramyocellular lipid droplets (HP:0012240) | 1.59722319 |
182 | Overriding aorta (HP:0002623) | 1.59656803 |
183 | Ectopic kidney (HP:0000086) | 1.58379556 |
184 | Fair hair (HP:0002286) | 1.56225440 |
185 | Leukodystrophy (HP:0002415) | 1.56014270 |
186 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.55694989 |
187 | Polymicrogyria (HP:0002126) | 1.52300300 |
188 | Decreased central vision (HP:0007663) | 1.51614119 |
189 | Abnormality of the renal medulla (HP:0100957) | 1.50385458 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.38894693 |
2 | EIF2AK1 | 3.74363417 |
3 | TRIB3 | 3.55543797 |
4 | ERN1 | 3.36116377 |
5 | MST4 | 3.28746297 |
6 | ZAK | 3.02209075 |
7 | IRAK3 | 2.60566125 |
8 | SCYL2 | 2.58342836 |
9 | TLK1 | 2.36561911 |
10 | CDC7 | 2.24145520 |
11 | TBK1 | 2.14250949 |
12 | TYK2 | 2.13507255 |
13 | BMX | 2.13228066 |
14 | ADRBK2 | 2.09965925 |
15 | FGFR4 | 2.08129429 |
16 | SIK1 | 2.03192831 |
17 | STK39 | 2.00570556 |
18 | VRK2 | 1.98827024 |
19 | INSRR | 1.98556927 |
20 | CAMK1D | 1.94150047 |
21 | WEE1 | 1.90112686 |
22 | TGFBR2 | 1.87711188 |
23 | MAP3K14 | 1.82727481 |
24 | NUAK1 | 1.74474258 |
25 | MAP4K1 | 1.70415210 |
26 | NEK9 | 1.69542291 |
27 | BMPR1B | 1.68960048 |
28 | PNCK | 1.65696920 |
29 | TAOK3 | 1.65391704 |
30 | WNK4 | 1.63410360 |
31 | FLT3 | 1.58504358 |
32 | JAK3 | 1.58162606 |
33 | JAK1 | 1.56171891 |
34 | PDK4 | 1.55686417 |
35 | PDK3 | 1.55686417 |
36 | MST1R | 1.54843912 |
37 | PKN2 | 1.50458954 |
38 | KIT | 1.46096678 |
39 | NME2 | 1.44959093 |
40 | PRKAA2 | 1.41246386 |
41 | EPHB1 | 1.37912836 |
42 | CHEK2 | 1.37657097 |
43 | IKBKE | 1.35588355 |
44 | MAP2K3 | 1.33556247 |
45 | MYLK | 1.32522821 |
46 | NEK2 | 1.31779653 |
47 | VRK1 | 1.31268487 |
48 | TTN | 1.29537857 |
49 | ILK | 1.28691422 |
50 | BLK | 1.24530766 |
51 | MAPK11 | 1.22327889 |
52 | BRSK2 | 1.21061412 |
53 | WNK3 | 1.20822535 |
54 | TSSK6 | 1.19355951 |
55 | JAK2 | 1.15572164 |
56 | IKBKB | 1.13721642 |
57 | PTK6 | 1.13400674 |
58 | MAP3K3 | 1.11710047 |
59 | PLK3 | 1.11165228 |
60 | DYRK2 | 1.08885911 |
61 | LRRK2 | 1.08618355 |
62 | IRAK4 | 1.08254827 |
63 | TAF1 | 1.06948440 |
64 | CAMK1G | 1.05730384 |
65 | PTK2B | 1.03525979 |
66 | MAPKAPK5 | 1.03161529 |
67 | IRAK1 | 1.02400323 |
68 | CAMKK2 | 1.01985821 |
69 | RIPK1 | 1.01751664 |
70 | EPHA3 | 1.01741340 |
71 | TEC | 1.01219569 |
72 | ZAP70 | 1.00436962 |
73 | BUB1 | 0.99620161 |
74 | TRIM28 | 0.98869441 |
75 | MAP2K7 | 0.98326751 |
76 | PLK1 | 0.98157454 |
77 | PIK3CG | 0.98052303 |
78 | FGFR3 | 0.97896497 |
79 | STK24 | 0.97754251 |
80 | LMTK2 | 0.97063996 |
81 | ADRBK1 | 0.96284275 |
82 | TIE1 | 0.95799735 |
83 | PDK2 | 0.95663044 |
84 | MAPKAPK3 | 0.92526622 |
85 | PBK | 0.90713236 |
86 | LATS1 | 0.90710520 |
87 | CSF1R | 0.90248433 |
88 | ABL2 | 0.88721226 |
89 | NME1 | 0.88563739 |
90 | PHKG1 | 0.88526763 |
91 | PHKG2 | 0.88526763 |
92 | CSK | 0.87612521 |
93 | LIMK1 | 0.86638273 |
94 | PINK1 | 0.85164102 |
95 | NEK1 | 0.85048248 |
96 | MAP2K1 | 0.82715855 |
97 | NLK | 0.82715820 |
98 | MAPK13 | 0.82175585 |
99 | FRK | 0.81985185 |
100 | BTK | 0.81369243 |
101 | AURKA | 0.80759472 |
102 | STK10 | 0.79857187 |
103 | ATR | 0.78754973 |
104 | DMPK | 0.78087972 |
105 | TTK | 0.77588835 |
106 | ITK | 0.77421664 |
107 | GRK5 | 0.77010316 |
108 | PLK2 | 0.76879715 |
109 | ACVR1B | 0.76727154 |
110 | GRK1 | 0.76295012 |
111 | PIM2 | 0.73408227 |
112 | KDR | 0.72992765 |
113 | PRKAA1 | 0.72962901 |
114 | CAMK1 | 0.72175222 |
115 | AURKB | 0.72173145 |
116 | STK38L | 0.72169221 |
117 | MAP3K13 | 0.71843558 |
118 | MAP3K7 | 0.71780635 |
119 | CDK6 | 0.68232068 |
120 | CHUK | 0.68059922 |
121 | SRPK1 | 0.67807277 |
122 | OBSCN | 0.67493359 |
123 | STK3 | 0.65595394 |
124 | MAP3K12 | 0.65224531 |
125 | MAP3K11 | 0.64962023 |
126 | RPS6KB2 | 0.64926521 |
127 | CDK9 | 0.64854725 |
128 | PDPK1 | 0.64693519 |
129 | RPS6KA4 | 0.64354640 |
130 | MAPK15 | 0.60877970 |
131 | RIPK4 | 0.60521098 |
132 | MAP3K5 | 0.58808021 |
133 | PKN1 | 0.58677385 |
134 | FER | 0.58457816 |
135 | CSNK1E | 0.58293126 |
136 | GSK3A | 0.57770236 |
137 | MAP3K1 | 0.57689240 |
138 | CSNK1G3 | 0.57641112 |
139 | TRPM7 | 0.57177618 |
140 | CSNK1G2 | 0.55688766 |
141 | EEF2K | 0.55211367 |
142 | DAPK1 | 0.55181061 |
143 | PIM1 | 0.54761242 |
144 | PDK1 | 0.54706832 |
145 | CDK14 | 0.54676773 |
146 | MUSK | 0.54676395 |
147 | GRK6 | 0.54574636 |
148 | OXSR1 | 0.54290237 |
149 | MAP3K4 | 0.53623812 |
150 | BRSK1 | 0.53338134 |
151 | SYK | 0.53179440 |
152 | IRAK2 | 0.53016153 |
153 | CDK8 | 0.51555138 |
154 | PAK1 | 0.50889738 |
155 | DAPK2 | 0.50559282 |
156 | MET | 0.49910812 |
157 | BMPR2 | 0.47857813 |
158 | MAPK12 | 0.47007300 |
159 | RPS6KA5 | 0.46915411 |
160 | PRKCG | 0.46645746 |
161 | PIK3CA | 0.44376265 |
162 | PRKG2 | 0.44114835 |
163 | DYRK1B | 0.42250327 |
164 | DAPK3 | 0.41770964 |
165 | PRKD1 | 0.41272172 |
166 | CHEK1 | 0.40858049 |
167 | ATM | 0.40813607 |
168 | CDK4 | 0.40443381 |
169 | PRKCQ | 0.39568674 |
170 | HIPK2 | 0.39406870 |
171 | MINK1 | 0.37926303 |
172 | CSNK1A1L | 0.37426189 |
173 | CCNB1 | 0.37010446 |
174 | AKT2 | 0.36706711 |
175 | CDK18 | 0.36007585 |
176 | CDK7 | 0.33703426 |
177 | CAMK2A | 0.33533832 |
178 | CDK15 | 0.32935031 |
179 | EPHB2 | 0.32931238 |
180 | CDK11A | 0.32330496 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.55674195 |
2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.49686897 |
3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.37556676 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.99702613 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88558765 |
6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.68107696 |
7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.67017007 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58161996 |
9 | Mismatch repair_Homo sapiens_hsa03430 | 2.57829961 |
10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.47210064 |
11 | DNA replication_Homo sapiens_hsa03030 | 2.44986413 |
12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.39694392 |
13 | Homologous recombination_Homo sapiens_hsa03440 | 2.39282171 |
14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.30356160 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.25494377 |
16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.22580143 |
17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20506093 |
18 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.10350818 |
19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01613027 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00538315 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.94288827 |
22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.91150635 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89993120 |
24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.83555268 |
25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.83471221 |
26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.83336069 |
27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.78330789 |
28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.76647434 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73274281 |
30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.72831054 |
31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.71725642 |
32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70919949 |
33 | Platelet activation_Homo sapiens_hsa04611 | 1.69727075 |
34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69410740 |
35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.66218406 |
36 | Base excision repair_Homo sapiens_hsa03410 | 1.58998806 |
37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.57718877 |
38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.56978860 |
39 | Ribosome_Homo sapiens_hsa03010 | 1.55709777 |
40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.54067523 |
41 | RNA polymerase_Homo sapiens_hsa03020 | 1.49363883 |
42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.49212071 |
43 | Phototransduction_Homo sapiens_hsa04744 | 1.48748241 |
44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.46844815 |
45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.44567548 |
46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44461849 |
47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.43322284 |
48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.41987689 |
49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38751835 |
50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.38489086 |
51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.38126687 |
52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34545662 |
53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32476040 |
54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.27512435 |
55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22847533 |
56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21428093 |
57 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18651389 |
58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15307430 |
59 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13290224 |
60 | RNA transport_Homo sapiens_hsa03013 | 1.13209658 |
61 | Purine metabolism_Homo sapiens_hsa00230 | 1.13033508 |
62 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13024070 |
63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10886963 |
64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10846198 |
65 | RNA degradation_Homo sapiens_hsa03018 | 1.10711003 |
66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09607121 |
67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06952937 |
68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03700217 |
69 | Cell cycle_Homo sapiens_hsa04110 | 1.02937347 |
70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98861902 |
71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98294932 |
72 | Bile secretion_Homo sapiens_hsa04976 | 0.96323370 |
73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.94361936 |
74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91567607 |
75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91388505 |
76 | ABC transporters_Homo sapiens_hsa02010 | 0.90628884 |
77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.90496660 |
78 | Insulin resistance_Homo sapiens_hsa04931 | 0.89627266 |
79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89311814 |
80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86569363 |
81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85150334 |
82 | Alcoholism_Homo sapiens_hsa05034 | 0.82936992 |
83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82105998 |
84 | Lysine degradation_Homo sapiens_hsa00310 | 0.81528726 |
85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80584327 |
86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78146351 |
87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77281575 |
88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76759985 |
89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76741531 |
90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75756339 |
91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74856549 |
92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70941986 |
93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69644684 |
94 | Legionellosis_Homo sapiens_hsa05134 | 0.68669324 |
95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68018431 |
96 | Protein export_Homo sapiens_hsa03060 | 0.67778164 |
97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67483790 |
98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66967783 |
99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66603569 |
100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66444853 |
101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66322361 |
102 | Lysosome_Homo sapiens_hsa04142 | 0.66145550 |
103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66049846 |
104 | Spliceosome_Homo sapiens_hsa03040 | 0.65317896 |
105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65251157 |
106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63857519 |
107 | Long-term depression_Homo sapiens_hsa04730 | 0.63751469 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61749150 |
109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61344403 |
110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61065650 |
111 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59831215 |
112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59650090 |
113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58036313 |
114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56777912 |
115 | Proteasome_Homo sapiens_hsa03050 | 0.56393653 |
116 | Morphine addiction_Homo sapiens_hsa05032 | 0.52160545 |
117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50544462 |
118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50018192 |
119 | Nicotine addiction_Homo sapiens_hsa05033 | 0.49761824 |
120 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49373495 |
121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48431740 |
122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48411172 |
123 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46152104 |
124 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45402771 |
125 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43333869 |
126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42635288 |
127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41880146 |
128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41313785 |
129 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38787426 |
130 | Malaria_Homo sapiens_hsa05144 | 0.38321337 |
131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37999695 |
132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37191879 |
133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36071509 |
134 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35460337 |
135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35299544 |
136 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34681891 |
137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34439706 |
138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34171913 |
139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32801987 |
140 | Pertussis_Homo sapiens_hsa05133 | 0.31901132 |
141 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30319286 |
142 | Tuberculosis_Homo sapiens_hsa05152 | 0.30101423 |
143 | Measles_Homo sapiens_hsa05162 | 0.29841605 |
144 | Hepatitis C_Homo sapiens_hsa05160 | 0.29692688 |
145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26060581 |
146 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25947824 |
147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25916073 |
148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25611692 |
149 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.25293754 |
150 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25274346 |
151 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.25168715 |
152 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24950403 |
153 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.24513906 |
154 | Influenza A_Homo sapiens_hsa05164 | 0.24000026 |
155 | Mineral absorption_Homo sapiens_hsa04978 | 0.23809373 |
156 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23089967 |